El Centro Médico Teknon, también conocido como la Clínica Teknon es un centro médico privado de Barcelona. Fue fundado en 1994 tomando como sede Can Vilana, un palacete de estilo neoclásico Can Vilana, en el barrio de Sant Gervasi-La Bonanova.​​

During the past decade, Centro Médico Teknon conducted 51 clinical trials. In the 10-year time frame, 51 clinical trials started and 15 clinical trials were completed, i.e. on average, 29.4% percent of trials that started reached the finish line to date. In the past 5 years, 22 clinical trials started and 10 clinical trials were completed. i.e. 45.5% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Centro Médico Teknon" #1 sponsor was "Centro Medico Teknon" with 6 trials, followed by "Shire" with 6 trials sponsored, "Servei Central d' Anestesiologia" with 5 trials sponsored, "Celgene" with 4 trials sponsored and "Hoffmann-La Roche" with 4 trials sponsored. Other sponsors include 42 different institutions and companies that sponsored additional 42 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Centro Médico Teknon" #1 collaborator was "Centro Medico Teknon" with 3 trials as a collaborator, "Gilead Sciences" with 3 trials as a collaborator, "AIXIAL Development" with 1 trials as a collaborator, "Azienda Ospedaliero, Universitaria Pisana" with 1 trials as a collaborator and "Clever Instruments S.L." with 1 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 30 trials.

According to Clinical.Site data, the most researched conditions in "Centro Médico Teknon" are "Ulcerative Colitis" (11 trials), "Crohn's Disease" (5 trials), "Crohn Disease" (4 trials), "Acute Lymphoblastic Leukemia" (2 trials) and "Acute Pain" (2 trials). Many other conditions were trialed in "Centro Médico Teknon" in a lesser frequency.

Most popular intervention types in "Centro Médico Teknon" are "Drug" (44 trials), "Other" (12 trials), "Procedure" (10 trials), "Device" (9 trials) and "Biological" (4 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (18 trials), "Filgotinib" (4 trials), "Ontamalimab" (4 trials), "Etrolizumab" (3 trials) and "Ozanimod" (3 trials). Other intervention names were less common.

The vast majority of trials in "Centro Médico Teknon" are 68 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Centro Médico Teknon". undefined are not yet recruiting, 14 are recruiting, 8 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 40 completed trials in Centro Médico Teknon, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Centro Médico Teknon, 2 "Phase 1" clinical trials were conducted, 11 "Phase 2" clinical trials and 29 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 13 trials that are defined as “Not Applicable".